RiVax

mutant recombinant RTA (ribotoxic A chain) ricin vaccine

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Connell, Terry D: 1 article (12/2015)
2.	Greene, Christopher J: 1 article (12/2015)
3.	Mandell, Lorrie M: 1 article (12/2015)
4.	Mantis, Nicholas J: 1 article (12/2015)
5.	Rong, Yinghui: 1 article (12/2015)
6.	Vance, David J: 1 article (12/2015)
7.	Brey, Robert N: 1 article (09/2011)
8.	Legler, Patricia M: 1 article (09/2011)
9.	Millard, Charles B: 1 article (09/2011)
10.	Smallshaw, Joan E: 1 article (09/2011)

1.	Poisoning 09/01/2011 - "RiVax is a recombinant protein that is currently under clinical development as part of a human vaccine to protect against ricin poisoning. "
2.	Inflammation (Inflammations) 12/01/2015 - "LT-IIa was of particular interest because as little as 0.03 μg when coadministered with RiVax or RVEc proved effective at augmenting ricin toxin-specific serum antibody titers with nominal evidence of local inflammation. "